Pilocytic Astrocytoma

Overview


Plain-Language Overview

Pilocytic Astrocytoma is a type of brain tumor that primarily affects the central nervous system, especially in children and young adults. It arises from astrocytes, which are star-shaped cells that support nerve cells in the brain. This tumor is generally slow-growing and considered benign, meaning it is less likely to spread aggressively. Symptoms often result from pressure on nearby brain structures, causing headaches, balance problems, or vision changes. Diagnosis usually involves imaging studies like MRI to identify the tumor's location and size. Treatment often includes surgery to remove the tumor, which can lead to good outcomes. Understanding this condition helps explain how brain tumors can impact neurological function.

Clinical Definition

Pilocytic Astrocytoma is a WHO grade I glioma characterized by a well-circumscribed, slow-growing neoplasm derived from astrocytes. It most commonly occurs in the cerebellum but can also arise in the optic pathways, brainstem, and cerebral hemispheres. The tumor is associated with a BRAF gene alteration, often a fusion involving KIAA1549-BRAF, leading to constitutive activation of the MAPK pathway. Histologically, it shows biphasic patterns with compacted bipolar cells and loose microcystic areas, along with Rosenthal fibers and eosinophilic granular bodies. Clinically, it presents with symptoms related to mass effect or increased intracranial pressure. Despite its neoplastic nature, it has a favorable prognosis due to its low proliferative index and responsiveness to surgical resection. It is a major differential diagnosis in pediatric brain tumors.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.